Pfizer-BioNTech says its COVID-19 vaccine safe, effective in kids aged 5-11

Subscribe to The Global Herald in Google News

CBC News published this video item, entitled “Pfizer-BioNTech says its COVID-19 vaccine safe, effective in kids aged 5-11” – below is their description.

Pfizer and BioNTech say their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds. They plan to seek approval to use the vaccine in children in that age range in the U.S., Europe and elsewhere as soon as possible.

CBC News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Subscribe to The Global Herald in Google News

About This Source - CBC News

CBC News is the division of the Canadian Broadcasting Corporation responsible for the news gathering and production of news programs on the corporation’s English-language operations, namely CBC Television, CBC Radio, CBC News Network, and CBC.ca.

CBC News is the largest news broadcaster in Canada. It frequently collaborates with its French-language counterpart, Radio-Canada Info, although the two are organizationally separate.

Recent from CBC News:

  • Moscow imposing strict lockdown to reduce COVID-19 case numbers
  • Anand ‘absolutely’ up to making a ‘real deep transformation’ in the military: Freeland
  • Former military 2nd-in-command says timing is right for a new defence minister
  • In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • FDA panel recommends Pfizer’s Covid vaccine for kids 5 to 11
  • Germany’s BioNTech to build Africa vaccine plant from 2022 • FRANCE 24 English
  • FDA Panel Backs Pfizer Covid Shot for Kids 5 to 11
  • How BioNTech Used Cancer Research To Create Its Covid Vaccine
  • President Biden Gets Covid-19 Booster��Shot
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Moscow imposing strict lockdown to reduce COVID-19 case numbers
  • Man who lied on COVID relief application spent loan on Pokemon card
  • Analysis Shows Growing Vaccine Inequality Among Children In America
  • FDA panel recommends Pfizer’s Covid vaccine for kids 5 to 11
  • Nicola Sturgeon says Cop26 will ‘inevitably’ pose Covid-19 transmission risk
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • FDA panel recommends Pfizer’s Covid vaccine for kids 5 to 11
  • Germany’s BioNTech to build Africa vaccine plant from 2022 • FRANCE 24 English
  • This Morning’s Top Headlines – October 27 | Morning News NOW
  • Pfizer COVID vaccine approved for booster program in Australia | 7NEWS
  • Pfizer booster shots to be available in Queensland from November | 7NEWS
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.

    Posting....